Health Canada authorized its first generic semaglutide injection referencing Ozempic in April 2026 and its first generic weight-management semaglutide referencing Wegovy in June 2026.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Health Canada authorized its first generic semaglutide injection referencing Ozempic in April 2026 and its first generic weight-management semaglutide referencing Wegovy in June 2026. Those decisions belong to exact products and indications. The authorization holder, presentation, current market status, prescription route, pharmacy record, and seller still need to match the current Canadian records linked on this page.
Resolve the exact identity of Semaglutide through Current WEGOVY prescribing information from National Library of Medicine, DailyMed. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.
No. A page using the name Semaglutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. Semaglutide is the active ingredient in several distinct prescription products. WEGOVY has product-specific authorizations in the United States and European Union, and Canada authorized generic semaglutide products in 2026. Those records do not make every semaglutide offer, compounded product, imported package, brand, indication, presentation, or seller equivalent or authorized in every country. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Health Canada authorized its first generic semaglutide injection referencing Ozempic in April 2026 and its first generic weight-management semaglutide referencing Wegovy in June 2026. Those decisions belong to exact products and indications. The authorization holder, presentation, current market status, prescription route, pharmacy record, and seller still need to match the current Canadian records linked on this page.
Primary identity source: Current WEGOVY prescribing information / National Library of Medicine, DailyMed ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Current WEGOVY prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Current WEGOVY prescribing information ↗Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Drug Product Database ↗Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Choosing a safe online pharmacy ↗Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.
Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.
Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.